Tawee Tanvetyanon

Summary

Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Country: USA

Publications

  1. ncbi Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis
    Tawee Tanvetyanon
    Head and Neck Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA
    Am J Otolaryngol 30:38-43. 2009
  2. ncbi Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands
    Tawee Tanvetyanon
    Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa FL 33612, USA
    Cancer 113:150-7. 2008
  3. ncbi Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer
    Tawee Tanvetyanon
    Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    J Clin Oncol 26:4610-6. 2008
  4. ncbi Prognostic factors for survival after salvage reirradiation of head and neck cancer
    Tawee Tanvetyanon
    Head and Neck and ThoracicPrograms, and the Statistic Core, H Lee Moffitt Cancer Center andResearch Institute, Tampa, FL, USA
    J Clin Oncol 27:1983-91. 2009
  5. ncbi Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma
    Tawee Tanvetyanon
    Head and Neck Program, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    Arch Otolaryngol Head Neck Surg 135:687-92. 2009
  6. ncbi Quality-of-care indicators for non-small cell lung cancer
    Tawee Tanvetyanon
    Department of Thoracic Oncology, the H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
    Cancer Control 16:335-41. 2009
  7. ncbi Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers
    Tawee Tanvetyanon
    Department of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    J Thorac Oncol 5:1018-24. 2010
  8. ncbi A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer
    Tawee Tanvetyanon
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA
    J Thorac Oncol 2:1091-7. 2007
  9. ncbi Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer
    Gerold Bepler
    Program and Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA
    J Thorac Oncol 3:1112-8. 2008
  10. ncbi Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer
    Gerold Bepler
    Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA
    J Thorac Oncol 6:553-8. 2011

Detail Information

Publications32

  1. ncbi Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis
    Tawee Tanvetyanon
    Head and Neck Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA
    Am J Otolaryngol 30:38-43. 2009
    ..Squamous cell carcinoma (SCC) is associated with IP in about 7% of cases. To date, there has been no pooled analysis to formulate a survival outcome associated with this rare condition...
  2. ncbi Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands
    Tawee Tanvetyanon
    Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa FL 33612, USA
    Cancer 113:150-7. 2008
    ..In the current study, the authors investigated the risk of lung cancer associated with beta-carotene in smokers or former smokers and surveyed the beta-carotene content in national brand multivitamins...
  3. ncbi Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer
    Tawee Tanvetyanon
    Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    J Clin Oncol 26:4610-6. 2008
    ....
  4. ncbi Prognostic factors for survival after salvage reirradiation of head and neck cancer
    Tawee Tanvetyanon
    Head and Neck and ThoracicPrograms, and the Statistic Core, H Lee Moffitt Cancer Center andResearch Institute, Tampa, FL, USA
    J Clin Oncol 27:1983-91. 2009
    ..Reirradiation is a treatment option, although it is associated with substantial toxicities. We investigated potential prognostic factors, including comorbidity and pre-existing organ dysfunction, for survival after reirradiation...
  5. ncbi Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma
    Tawee Tanvetyanon
    Head and Neck Program, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    Arch Otolaryngol Head Neck Surg 135:687-92. 2009
    ..To investigate the potential value of postoperative concurrent chemoradiation among patients with high-risk salivary gland carcinomas...
  6. ncbi Quality-of-care indicators for non-small cell lung cancer
    Tawee Tanvetyanon
    Department of Thoracic Oncology, the H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
    Cancer Control 16:335-41. 2009
    ..To date, the literature on quality-of-care indicators for non-small cell lung cancer (NSCLC) has not been reviewed...
  7. ncbi Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers
    Tawee Tanvetyanon
    Department of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    J Thorac Oncol 5:1018-24. 2010
    ..For those undergoing surgery, limited information exists on the relationship between tumor size and survival...
  8. ncbi A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer
    Tawee Tanvetyanon
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA
    J Thorac Oncol 2:1091-7. 2007
    ..We evaluated available literatures to summarize the state of current knowledge and provide suggestions for future studies...
  9. ncbi Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer
    Gerold Bepler
    Program and Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA
    J Thorac Oncol 3:1112-8. 2008
    ..The goal was to achieve a disease response rate of 50% and to determine if the expression levels of genes associated with GP metabolism are predictive of response...
  10. ncbi Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer
    Gerold Bepler
    Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA
    J Thorac Oncol 6:553-8. 2011
    ..A reduction in both local and distant recurrence is needed to improve patients' outcome. Performing molecular studies on serially collected tumor specimens may result in a better selection of therapeutic options...
  11. ncbi Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer
    Eric B Haura
    Department of Thoracic Oncology and Biostatistics, Clinical Trials and Clinical Pharmacology Core, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 9497, USA
    J Clin Oncol 28:1387-94. 2010
    ....
  12. ncbi Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis
    Tawee Tanvetyanon
    Biostatistics Division, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Dr, Tampa, FL 33613, USA
    J Clin Oncol 26:1142-7. 2008
    ..However, some suggest that the survival outcome among patients with a synchronous metastasis is poor. It remains unclear whether this treatment approach is warranted among those with synchronous metastasis...
  13. ncbi Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer
    George Simon
    Program and Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 9497, USA
    J Clin Oncol 25:2741-6. 2007
    ..We hypothesized that selection of double-agent chemotherapy based on tumoral RRM1 and ERCC1 expression would be feasible and beneficial for patients with advanced NSCLC...
  14. ncbi Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings
    Virendra Kumar
    Department of Imaging, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 9416, USA
    Clin Nucl Med 38:175-82. 2013
    ..In this study, we measured test-retest reproducibility of SUV measurements under clinical practice conditions and recorded recognized deviations from protocol compliance...
  15. ncbi Physician practice in the discontinuation of statins among patients with advanced lung cancer
    Tawee Tanvetyanon
    H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
    J Palliat Care 22:281-5. 2006
    ..Lipid monitoring was suboptimal and, when it occurred, indicated the lipid goal was rarely achieved...
  16. ncbi Effects of self-directed stress management training and home-based exercise on stress management skills in cancer patients receiving chemotherapy
    Kristin M Phillips
    Division of Population Science, Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, MRC PSY, Tampa, FL 33612, USA
    Stress Health 28:368-75. 2012
    ..05). This study provides support for including an exercise component in SM interventions for cancer patients receiving chemotherapy (clinicaltrials.gov identifier: NCT00740038)...
  17. ncbi Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma
    Tawee Tanvetyanon
    Hematology and Oncology Section, Edward Hines, Jr. Veteran Administration Hospital, Hines, IL 60141, USA
    Cancer 106:1554-9. 2006
    ..However, the intensity of anemia management is low. A low baseline hemoglobin level and the reception of multiple concurrent chemotherapeutic agents are considered to be the main risk factors of anemia. Cancer 2006...
  18. ncbi Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors
    Tawee Tanvetyanon
    Cancer 103:1756-7; author reply 1757-8. 2005
  19. ncbi Acute lung injury associated with vinorelbine
    Tawee Tanvetyanon
    Division of Hematology/Oncology, and Lung Transplantation Program, Division of Pulmonary and Critical Care Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
    J Clin Oncol 24:1952-3. 2006
  20. ncbi Octreotide for bleeding as a result of hepatocellular carcinoma invasion of the gastrointestinal tract
    Tawee Tanvetyanon
    J Gastroenterol Hepatol 18:231-2. 2003
  21. ncbi The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version
    Thitiya Sirisinha
    Medical Oncology Unit, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
    J Med Assoc Thai 85:1210-9. 2002
    ..The initial findings of the present study indicate that the Thai version of the EORTC QLQ-C30 is reliable. A validating process of this version is in progress with active patients accrual ongoing at present...
  22. ncbi Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa
    Tawee Tanvetyanon
    Division of Hematology Oncology, Loyola University Stritch School of Medicine, Maywood, IL 60153 3304, USA
    Ann Pharmacother 38:418-21. 2004
    ..To describe severe hypocalcemia and acute renal failure associated with zoledronic acid and interferon alfa in a patient with metastatic carcinoid tumors...
  23. ncbi HER-2 and fluorescent in situ hybridization to evaluate breast cancer
    Tawee Tanvetyanon
    JAMA 292:328; author reply 328-9. 2004
  24. ncbi Mucoepidermoid carcinoma of the lung presenting as a cavitary lesion
    Tawee Tanvetyanon
    Department of Medicine, Loyola University Medical Center and Hines Veteran Affair Hospital, Maywood, IL, USA
    J Med Assoc Thai 87:988-91. 2004
    ..High-grade mucoepidermoid carcinoma of the lung may present as a cavitary lesion. The presence of M. tuberculosis should not preclude clinicians from pursuing adequate diagnostic procedures for a possible malignant lesion...
  25. ncbi Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy
    Tawee Tanvetyanon
    Division of Hematology and Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois 60153, USA
    Cancer 103:237-41. 2005
    ..The practices of interest are the uses of dual-energy X-ray absorptiometry (DXA) scans, bisphosphonates, calcium or vitamin D supplement, calcitonin, or estrogen...
  26. ncbi Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
    Tawee Tanvetyanon
    J Natl Cancer Inst 97:70; author reply 70-1. 2005
  27. ncbi Neoadjuvant therapy: an emerging concept in oncology
    Tawee Tanvetyanon
    Division of Hematology Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
    South Med J 98:338-44. 2005
    ..To date, the survival benefits of neoadjuvant therapy for resectable non-small cell lung, esophageal, gastric, and prostate cancer remains under investigation...
  28. ncbi Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
    Tawee Tanvetyanon
    Division of Hematology Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA
    Anticancer Res 25:429-33. 2005
    ..It seems possible that fludarabine, an immunosuppressive chemotherapy, accelerated the occurrence and progression of malignant mesothelioma during the therapy for his B-PLL...
  29. ncbi Molecular prediction of recurrence of breast cancer
    Tawee Tanvetyanon
    N Engl J Med 352:1605-7; author reply 1605-7. 2005
  30. ncbi Treatment of localized lymphoma
    Tawee Tanvetyanon
    N Engl J Med 352:2449-51; author reply 2449-51. 2005
  31. ncbi Consideration before administering cytotoxic chemotherapy to the critically ill
    Tawee Tanvetyanon
    Crit Care Med 33:2689-91. 2005
  32. ncbi Concurrent administration of interferon alfa-2b and beta-1a
    Tawee Tanvetyanon
    Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA
    Ann Pharmacother 37:77-9. 2003
    ..To describe the concurrent use of interferon (IFN) alfa and beta in a patient with multiple sclerosis (MS) and chronic myeloid leukemia (CML)...